arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Senti Biosciences Holdings, Inc.

SNTI

$0.35 ▲ +0.03 (+10.04%) at close

23 Visible periods

23 Metrics

Absolute Benchmarks

Price Chart

Health

Weak

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Senti Biosciences Holdings, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $10.9M

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC 336.6% ↗

FCF / Share $-0.46 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

23-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$17.00K

↑ +6.2% —

Net Income Profit after all expenses

$-4.22M

↑ +70.1% —

FCF / Share Free cash flow per share

$-0.46

↓ -89.4% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -972.2% is weak on an absolute basis (target > 10%)
FCF / Net IncomeFCF / Net Income of 0.71x is caution on an absolute basis (target > 1x)

Health Breakdown

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Feb 28, 2021 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	N/M	N/M	N/M	N/M	-80.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1111%)	-31.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-488%)	16.5% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+106%)	-92.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1257%)	60.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+651%)	71.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+791%)	—	—	—	—	—	—
EPS Growth YoY (%)	26.8% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	90.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	22.6% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	89.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	77.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	45.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	85.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-85.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	41.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	38.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-74.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	10.5% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	51.2% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	88.7% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	93.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	90.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	79.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	70.1% Excellent ↑ Excellent Improving Year-over-year change in net income	70.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-2271.6% Weak ↓ Weak Declining Year-over-year change in net income	-16.5% Weak ↓ Weak Declining Year-over-year change in net income	-16.5% Weak ↓ Weak Declining Year-over-year change in net income	-16.5% Weak ↓ Weak Declining Year-over-year change in net income	96.7% Excellent ↑ Excellent Improving Year-over-year change in net income	35.3% Excellent ↑ Excellent Improving Year-over-year change in net income	35.3% Excellent ↑ Excellent Improving Year-over-year change in net income	35.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-2.8% Weak ↑ Weak Improving Year-over-year change in net income	-58.6% Weak → Weak Stable Year-over-year change in net income	-58.6% Weak ↓ Weak Declining Year-over-year change in net income	-58.6% Weak ↓ Weak Declining Year-over-year change in net income	-67.0% Weak ↑ Weak Improving Year-over-year change in net income	43.8% Excellent ↑ Excellent Improving Year-over-year change in net income	43.8% Excellent Excellent Year-over-year change in net income	-1002276.9% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	82.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	45.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	50.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	90.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-73.7% Weak Weak Compound annual revenue growth over 3 years	-76.8% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-53.6% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Feb 28, 2021 10-K ↗
FCF / Net Income (x)	3.38x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.77x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.00x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	22.16x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.38x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.22x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.48x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.46x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.46x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.00x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Feb 28, 2021 10-K ↗
Return on Invested Capital (%)	336.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-142.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-263.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-164.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-53.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-34.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-49.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-75.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-23.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-41.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	7.6% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	7.7% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	8.9% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	7.8% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-43.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-36.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-16.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-33.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-11.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	124.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+727%)	-164.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1197%)	-258.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1826%)	-173.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1258%)	-57.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-482%)	-37.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-349%)	-2.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-116%)	-75.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-605%)	-27.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-283%)	-21.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-244%)	-28.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-286%)	-22.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-250%)	-19.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-228%)	-16.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-211%)	-14.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-195%)	-8.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-156%)	-7.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-151%)	9.7% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-35%)	9.8% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-35%)	20.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+38%)	23.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+54%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Feb 28, 2021 10-K ↗
Net Debt (USD)	$-6.46M	$-8.94M	$-16.42M	$-12.24M	$-21.58M	$-33.80M	$-48.28M	$-10.48M	$-15.86M	$-23.72M	$-35.93M	$-39.43M	$-36.75M	$-31.60M	$-57.62M	$-114.94M	$-139.80M	$-38.14M	$-56.03M	$-73.69M	$-82.94M	$0.00	$0.00

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Feb 28, 2021 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	—	—	—	—	—	$0.00	$0.00	$0.00	—	$0.08	$0.21	$0.29	—	$0.41	$1.01	$3.48	—	$3.77	$2.73	—	—
Basic EPS, GAAP (USD)	$-0.41	$-0.14	$-0.48	$-0.69	$-0.56	$-1.41	$-0.62	$-6.31	$-2.45	$-2.60	$-4.19	$-3.40	$-4.20	$-4.20	$-2.40	$-3.80	$-8.60	$-37.20	$-36.70	$-39.00	$-41.30	—	—
Free Cash Flow per Share (USD)	$-0.46	$-0.24	—	$-0.36	—	$-1.40	—	—	—	$-2.56	—	—	—	$-5.18	—	—	—	$-54.99	—	$-33.28	$-47.64	—	—
Book Value per Share (USD)	$-0.11	$0.08	$0.18	$0.31	$0.94	$1.46	$5.31	$3.49	$9.66	$12.27	$14.64	$18.65	$21.91	$25.49	$28.88	$32.16	$35.57	$-384.10	$-374.97	$-346.45	$-311.56	—	—
Tangible Book Value per Share (USD)	$-0.11	$0.08	$0.18	$0.31	$0.94	$1.46	$5.31	$3.49	$9.66	$12.27	$14.64	$18.65	$21.91	$25.49	$28.88	$32.16	$35.57	$-384.10	$-374.97	$-346.45	$-311.56	—	—
Basic Weighted Avg Shares (shares)	31.14M	30.97M	—	26.23M	26.08M	10.01M	—	4.58M	4.57M	4.57M	—	4.45M	4.43M	4.41M	—	4.34M	1.34M	317,125	—	292,596	290,910	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Feb 28, 2021 10-K ↗
Working Capital (USD)	$-2.76M	$522.00K	$9.30M	$6.13M	$22.53M	$34.49M	$45.81M	$8.32M	$35.27M	$46.06M	$58.53M	$68.89M	$53.07M	$67.64M	$84.53M	$103.92M	$126.12M	—	$45.65M	—	—	—	—
Total Equity (USD)	$-3.40M	$2.56M	$5.59M	$8.12M	$24.65M	$37.86M	$25.65M	$15.99M	$44.15M	$56.09M	$66.91M	$82.94M	$97.42M	$112.34M	$127.26M	$140.34M	$154.27M	$-121.81M	$-111.46M	$-101.37M	$-90.64M	$0.00	$0.00

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Feb 28, 2021 10-K ↗
Sales/Revenue/Turnover (USD)	$17.00K	$16.00K	—	—	—	—	$0.00	$0.00	$0.00	$0.00	$0.00	$338.00K	$937.00K	$1.29M	$59.00K	$1.77M	$1.36M	$1.10M	$793.00K	$1.10M	$793.00K	—	—
Depreciation Expense (USD)	$667.00K	$688.00K	$893.00K	$904.00K	—	$926.00K	$937.00K	—	—	$984.00K	$992.00K	—	$800.00K	$467.00K	$452.00K	$400.00K	$300.00K	$240.00K	$226.00K	$200.00K	$200.00K	—	—
Net Income, GAAP (USD)	$-4.22M	$-4.22M	$-14.47M	$-14.11M	$-14.11M	$-14.11M	$-610.00K	$-12.11M	$-12.11M	$-12.11M	$-18.72M	$-18.72M	$-18.72M	$-18.72M	$-18.21M	$-11.81M	$-11.81M	$-11.81M	$-10.90M	$-21.00M	$-21.00M	$-1.18K	—
Operating Cash Flow (USD)	$-14.25M	$-7.48M	$-6.88M	$-9.45M	—	$-14.05M	$-13.50M	—	—	$-11.68M	$-7.04M	—	—	$-16.30M	$-9.01M	—	—	$-10.06M	$-11.97M	$-8.80M	$-13.86M	$0.00	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 23 quarters

Senti Biosciences Holdings, Inc.

Analytical Summary

23-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare SNTI with peers